Usefulness of neutrophil-to-lymphocyte ratio to predict in-hospital outcomes in infective endocarditis

Canadian Journal of Cardiology

Volumn 29, Issue 12, 2013, Pages 1672-1678

  Turak, Osman ^a   Özcan, Firat ^a   Işleyen, Ahmet ^a   Başar, F Nurcan ^a   Gül, Murat ^a   Yilmaz, Samet ^a   Sökmen, Erdoǧan ^a   Yüzgeçer, Hüseyin ^a   Lafçi, Gökhan ^a   Topaloǧlu, Serkan ^a   Aydoǧdu, Sinan ^a  

^a TURKIYE YUKSEK IHTISAS HOSPITAL   (Turkey)

Author keywords

[No Author keywords available]

Indexed keywords

C REACTIVE PROTEIN; HEMOGLOBIN; HIGH DENSITY LIPOPROTEIN;

ADULT; AGED; ALPHA HEMOLYTIC STREPTOCOCCUS; ARTICLE; BACTERIAL ENDOCARDITIS; BRUCELLA MELITENSIS; CANDIDA ALBICANS; CELL COUNT; CENTRAL NERVOUS SYSTEM DISEASE; CLINICAL FEATURE; COAGULASE NEGATIVE STAPHYLOCOCCUS; CONGESTIVE HEART FAILURE; DIAGNOSTIC ACCURACY; DIAGNOSTIC TEST ACCURACY STUDY; ECHOCARDIOGRAPHY; FEMALE; HEART VALVE REGURGITATION; HEMOGLOBIN BLOOD LEVEL; HOSPITAL ADMISSION; HUMAN; KIDNEY FAILURE; LEUKOCYTE COUNT; LIPOPROTEIN BLOOD LEVEL; LYMPHOCYTE; MAJOR CLINICAL STUDY; MALE; MORTALITY; NEUTROPHIL; NEUTROPHIL TO LYMPHOCYTE RATIO; OUTCOME ASSESSMENT; PREDICTOR VARIABLE; PROSTHETIC VALVE DYSFUNCTION; RETROSPECTIVE STUDY; SENSITIVITY AND SPECIFICITY; STAPHYLOCOCCUS AUREUS; STAPHYLOCOCCUS INFECTION;

ADULT; AGED; COMORBIDITY; ECHOCARDIOGRAPHY; ECHOCARDIOGRAPHY, TRANSESOPHAGEAL; ENDOCARDITIS; FEMALE; HEART VALVE PROSTHESIS; HOSPITAL MORTALITY; HUMANS; KAPLAN-MEIER ESTIMATE; LEUKOCYTE COUNT; LYMPHOCYTE COUNT; MALE; MIDDLE AGED; NEUTROPHILS; PATIENT ADMISSION; PATIENT OUTCOME ASSESSMENT; PREDICTIVE VALUE OF TESTS; PROSTHESIS-RELATED INFECTIONS; RETROSPECTIVE STUDIES; STAPHYLOCOCCAL INFECTIONS; TURKEY; YOUNG ADULT;

EID: 84888293059     PISSN: 0828282X     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.cjca.2013.05.005     Document Type: Article

References (29)

1. Baddour L.M., Wilson W.R., Bayer A.S., et al. Infective endocarditis: diagnosis, antimicrobial therapy, and management of complications: a statement for healthcare professionals from the Committee on Rheumatic Fever, Endocarditis, and Kawasaki Disease, Council on Cardiovascular Disease in the Young, and the Councils on Clinical Cardiology, Stroke, and Cardiovascular Surgery and Anesthesia, American Heart Association: endorsed by the Infectious Diseases Society of America. Circulation 2005, 111:e394-e434.
2. Habib G., Hoen B., Tornos P., et al. Guidelines on the prevention, diagnosis, and treatment of infective endocarditis (new version 2009): the Task Force on the Prevention, Diagnosis, and Treatment of Infective Endocarditis of the European Society of Cardiology (Esc). Endorsed by the European Society of Clinical Microbiology and Infectious Diseases (Escmid) and the International Society of Chemotherapy (ISC) for Infection and Cancer. Eur Heart J 2009, 30:2369-2413.
3. Tornos P., Gonzalez-Alujas T., Thuny F., Habib G. Infective endocarditis: the European viewpoint. Curr Probl Cardiol 2011, 36:175-222.
4. Duval X., Delahaye F., Alla F., et al. Temporal trends in infective endocarditis in the context of prophylaxis guideline modifications: three successive population-based surveys. JAm Coll Cardiol 2012, 59:1968-1976.
5. Cay S., Gurel O.M., Korkmaz S. Clinical and epidemiological characteristics of infective endocarditis. Arch Turk Soc Cardiol 2009, 37:182-186.
6. Grabowski M., Hryniewiecki T., Stepinska J. Novel markers of cerebral embolism in the course of infective endocarditis. Int J Cardiol 2012, 154:90-92.
7. Watkin R.W., Harper L.V., Vernallis A.B., et al. Pro-inflammatory cytokines IL6, TNF-alpha, IL1beta, procalcitonin, lipopolysaccharide binding protein and C-reactive protein in infective endocarditis. JInfect 2007, 55:220-225.
8. Heiro M., Helenius H., Sundell J., et al. Utility of serum C-reactive protein in assessing the outcome of infective endocarditis. Eur Heart J 2005, 26:1873-1881.
9. Roca B., Marco J.M. Presentation and outcome of infective endocarditis in Spain: a retrospective study. Int J Infect Dis 2007, 11:198-203.
10. de Jager C.P., van Wijk P.T., Mathoera R.B., et al. Lymphocytopenia and neutrophil-lymphocyte count ratio predict bacteremia better than conventional infection markers in an emergency care unit. Crit Care 2010, 14:R192.
11. Terradas R., Grau S., Blanch J., et al. Eosinophil count and neutrophil-lymphocyte count ratio as prognostic markers in patients with bacteremia: a retrospective cohort study. PLoS One 2012, 7:e42860.
12. de Jager C.P., Wever P.C., Gemen E.F., et al. The neutrophil-lymphocyte count ratio in patients with community-acquired pneumonia. PLoS One 2012, 7:e46561.
13. Turak O., Ozcan F., Isleyen A., et al. Usefulness of the neutrophil-to-lymphocyte ratio to predict bare-metal stent restenosis. Am J Cardiol 2012, 110:1405-1410.
14. Akpek M., Kaya M.G., Lam Y.Y., et al. Relation of neutrophil/lymphocyte ratio to coronary flow to in-hospital major adverse cardiac events in patients with ST-elevated myocardial infarction undergoing primary coronary intervention. Am J Cardiol 2012, 110:621-627.
15. Horne B.D., Anderson J.L., John J.M., et al. Which white blood cell subtypes predict increased cardiovascular risk?. JAm Coll Cardiol 2005, 45:1638-1643.
16. Duffy B.K., Gurm H.S., Rajagopal V., et al. Usefulness of an elevated neutrophil to lymphocyte ratio in predicting long-term mortality after percutaneous coronary intervention. Am J Cardiol 2006, 97:993-996.
17. Gibson P.H., Croal B.L., Cuthbertson B.H., et al. Preoperative neutrophil-lymphocyte ratio and outcome from coronary artery bypass grafting. Am Heart J 2007, 154:995-1002.
18. Li J.S., Sexton D.J., Mick N., et al. Proposed modifications to the Duke criteria for the diagnosis of infective endocarditis. Clin Infect Dis 2000, 30:633-638.
19. Menges T., Engel J., Welters I., et al. Changes in blood lymphocyte populations after multiple trauma: association with posttraumatic complications. Crit Care Med 1999, 27:733-740.
20. Wyllie D.H., Bowler I.C., Peto T.E. Relation between lymphopenia and bacteraemia in UK adults with medical emergencies. JClin Pathol 2004, 57:950-955.
21. Zahorec R. Ratio of neutrophil to lymphocyte counts-rapid and simple parameter of systemic inflammation and stress in critically ill. Bratisl Lek Listy 2001, 102:5-14.
22. Ayala A., Herdon C.D., Lehman D.L., Ayala C.A., Chaudry I.H. Differential induction of apoptosis in lymphoid tissues during sepsis: variation in onset, frequency, and the nature of the mediators. Blood 1996, 87:4261-4275.
23. Papa A., Emdin M., Passino C., et al. Predictive value of elevated neutrophil-lymphocyte ratio on cardiac mortality in patients with stable coronary artery disease. Clin Chim Acta 2008, 395:27-31.
24. Nunez J., Nunez E., Bodi V., et al. Usefulness of the neutrophil to lymphocyte ratio in predicting long-term mortality in ST segment elevation myocardial infarction. Am J Cardiol 2008, 101:747-752.
25. Kaya MG, Akpek M, Lam YY, etal. Prognostic value of neutrophil/lymphocyte ratio in patients with ST-elevated myocardial infarction undergoing primary coronary intervention: a prospective, multicenter study. Int J Cardiol 2013;168:1154-9.
26. Tamhane U.U., Aneja S., Montgomery D., et al. Association between admission neutrophil to lymphocyte ratio and outcomes in patients with acute coronary syndrome. Am J Cardiol 2008, 102:653-657.
27. Uthamalingam S., Patvardhan E.A., Subramanian S., et al. Utility of the neutrophil to lymphocyte ratio in predicting long-term outcomes in acute decompensated heart failure. Am J Cardiol 2011, 107:433-438.
28. Uthamalingam S., Gurm G.S., Daley M., Flynn J., Capodilupo R. Usefulness of acute delirium as a predictor of adverse outcomes in patients >65 years of age with acute decompensated heart failure. Am J Cardiol 2011, 108:402-408.
29. Grabowski M., Hryniewiecki T., Janas J., Stepinska J. Clinically overt and silent cerebral embolism in the course of infective endocarditis. JNeurol 2011, 258:1133-1139.